Annexin A8 deficiency delays atherosclerosis progression

Abstract Background Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipids and leukocytes within the arterial wall. By studying the aortic transcriptome of atherosclerosis‐prone apolipoprotein E (ApoE−/−) mice, we aimed to identify novel players in the progress...

Full description

Saved in:
Bibliographic Details
Main Authors: Carmen Gutiérrez‐Muñoz, Rafael Blázquez‐Serra, Irene San Sebastian‐Jaraba, Sandra Sanz‐Andrea, Maria J. Fernández‐Gómez, Gonzalo Nuñez‐Moreno, Pablo Mínguez, Joan Carles Escolá‐Gil, Paula Nogales, Veronique Ollivier, Jose L. Martín‐Ventura, Benoit Ho‐Tin Noe, Ursula Rescher, Nerea Méndez‐Barbero, Luis M. Blanco‐Colio
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Clinical and Translational Medicine
Subjects:
Online Access:https://doi.org/10.1002/ctm2.70176
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586807161651200
author Carmen Gutiérrez‐Muñoz
Rafael Blázquez‐Serra
Irene San Sebastian‐Jaraba
Sandra Sanz‐Andrea
Maria J. Fernández‐Gómez
Gonzalo Nuñez‐Moreno
Pablo Mínguez
Joan Carles Escolá‐Gil
Paula Nogales
Veronique Ollivier
Jose L. Martín‐Ventura
Benoit Ho‐Tin Noe
Ursula Rescher
Nerea Méndez‐Barbero
Luis M. Blanco‐Colio
author_facet Carmen Gutiérrez‐Muñoz
Rafael Blázquez‐Serra
Irene San Sebastian‐Jaraba
Sandra Sanz‐Andrea
Maria J. Fernández‐Gómez
Gonzalo Nuñez‐Moreno
Pablo Mínguez
Joan Carles Escolá‐Gil
Paula Nogales
Veronique Ollivier
Jose L. Martín‐Ventura
Benoit Ho‐Tin Noe
Ursula Rescher
Nerea Méndez‐Barbero
Luis M. Blanco‐Colio
author_sort Carmen Gutiérrez‐Muñoz
collection DOAJ
description Abstract Background Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipids and leukocytes within the arterial wall. By studying the aortic transcriptome of atherosclerosis‐prone apolipoprotein E (ApoE−/−) mice, we aimed to identify novel players in the progression of atherosclerosis. Methods RNA‐Seq analysis was performed on aortas from ApoE−/− and wild‐type mice. AnxA8 expression was assessed in human and mice atherosclerotic tissue and healthy aorta. ApoE−/− mice lacking systemic AnxA8 (ApoE−/−AnxA8−/−) were generated to assess the effect of AnxA8 deficiency on atherosclerosis. Bone marrow transplantation (BMT) was also performed to generate ApoE−/− lacking AnxA8 specifically in bone marrow‐derived cells. Endothelial‐specific AnxA8 silencing in vivo was performed in ApoE−/− mice. The functional role of AnxA8 was analysed in cultured murine cells. Results RNA‐Seq unveiled AnxA8 as one of the most significantly upregulated genes in atherosclerotic aortas of ApoE−/− compared to wild‐type mice. Moreover, AnxA8 was upregulated in human atherosclerotic plaques. Germline deletion of AnxA8 decreased the atherosclerotic burden, the size and volume of atherosclerotic plaques in the aortic root. Plaques of ApoE−/−AnxA8−/− were characterized by lower lipid and inflammatory content, smaller necrotic core, thicker fibrous cap and less apoptosis compared with those in ApoE−/−AnxA8+/+. BMT showed that hematopoietic AnxA8 deficiency had no effect on atherosclerotic progression. Oxidized low‐density lipoprotein (ox‐LDL) increased AnxA8 expression in murine aortic endothelial cells (MAECs). In vitro experiments revealed that AnxA8 deficiency in MAECs suppressed P/E‐selectin and CD31 expression and secretion induced by ox‐LDL with a concomitant reduction in platelet and leukocyte adhesion. Intravital microscopy confirmed the reduction in leukocyte and platelet adhesion in ApoE−/−AnxA8−/− mice. Finally, endothelial‐specific silencing of AnxA8 decreased atherosclerosis progression. Conclusion Our findings demonstrate that AnxA8 promotes the progression of atherosclerosis by modulating endothelial−leukocyte interactions. Interventions capable of reducing AnxA8 expression in endothelial cells may delay atherosclerotic plaque progression. Key points This study shows that AnxA8 is upregulated in aorta of atheroprone mice and in human atherosclerotic plaques. Germline AnxA8 deficiency reduces platelet and leukocyte recruitment to activated endothelium as well as atherosclerotic burden, plaque size, and macrophage accumulation in mice. AnxA8 regulates oxLDL‐induced adhesion molecules expression in aortic endothelial cells. Our data strongly suggest that AnxA8 promotes disease progression through regulation of adhesion and influx of immune cells to the intima. Endothelial specific silencing of AnxA8 reduced atherosclerosis progression. Therapeutic interventions to reduce AnxA8 expression may delay atherosclerosis progression.
format Article
id doaj-art-9e63958f007e4a0797c1405762a31340
institution Kabale University
issn 2001-1326
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Clinical and Translational Medicine
spelling doaj-art-9e63958f007e4a0797c1405762a313402025-01-25T04:00:39ZengWileyClinical and Translational Medicine2001-13262025-01-01151n/an/a10.1002/ctm2.70176Annexin A8 deficiency delays atherosclerosis progressionCarmen Gutiérrez‐Muñoz0Rafael Blázquez‐Serra1Irene San Sebastian‐Jaraba2Sandra Sanz‐Andrea3Maria J. Fernández‐Gómez4Gonzalo Nuñez‐Moreno5Pablo Mínguez6Joan Carles Escolá‐Gil7Paula Nogales8Veronique Ollivier9Jose L. Martín‐Ventura10Benoit Ho‐Tin Noe11Ursula Rescher12Nerea Méndez‐Barbero13Luis M. Blanco‐Colio14Vascular Research Laboratory, IIS‐Fundación Jiménez Díaz Madrid SpainVascular Research Laboratory, IIS‐Fundación Jiménez Díaz Madrid SpainVascular Research Laboratory, IIS‐Fundación Jiménez Díaz Madrid SpainVascular Research Laboratory, IIS‐Fundación Jiménez Díaz Madrid SpainVascular Research Laboratory, IIS‐Fundación Jiménez Díaz Madrid SpainBioinformatics Unit Department of Genetics & Genomics IIS‐Fundación Jiménez Díaz Madrid SpainBioinformatics Unit Department of Genetics & Genomics IIS‐Fundación Jiménez Díaz Madrid SpainInstitut d'Investigacions Biomèdiques (IIB) Sant Pau Barcelona SpainCentro Nacional de Investigaciones Cardiovasculares Madrid SpainLaboratory for Vascular Translation Science Inserm U1148, Paris Bichat Hospital Paris FranceVascular Research Laboratory, IIS‐Fundación Jiménez Díaz Madrid SpainLaboratory for Vascular Translation Science Inserm U1148, Paris Bichat Hospital Paris FranceCenter for Molecular Biology of Inflammation Research Group Regulatory Mechanisms of Inflammation, Institute of Medical Biochemistry, University of Muenster Muenster GermanyVascular Research Laboratory, IIS‐Fundación Jiménez Díaz Madrid SpainVascular Research Laboratory, IIS‐Fundación Jiménez Díaz Madrid SpainAbstract Background Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipids and leukocytes within the arterial wall. By studying the aortic transcriptome of atherosclerosis‐prone apolipoprotein E (ApoE−/−) mice, we aimed to identify novel players in the progression of atherosclerosis. Methods RNA‐Seq analysis was performed on aortas from ApoE−/− and wild‐type mice. AnxA8 expression was assessed in human and mice atherosclerotic tissue and healthy aorta. ApoE−/− mice lacking systemic AnxA8 (ApoE−/−AnxA8−/−) were generated to assess the effect of AnxA8 deficiency on atherosclerosis. Bone marrow transplantation (BMT) was also performed to generate ApoE−/− lacking AnxA8 specifically in bone marrow‐derived cells. Endothelial‐specific AnxA8 silencing in vivo was performed in ApoE−/− mice. The functional role of AnxA8 was analysed in cultured murine cells. Results RNA‐Seq unveiled AnxA8 as one of the most significantly upregulated genes in atherosclerotic aortas of ApoE−/− compared to wild‐type mice. Moreover, AnxA8 was upregulated in human atherosclerotic plaques. Germline deletion of AnxA8 decreased the atherosclerotic burden, the size and volume of atherosclerotic plaques in the aortic root. Plaques of ApoE−/−AnxA8−/− were characterized by lower lipid and inflammatory content, smaller necrotic core, thicker fibrous cap and less apoptosis compared with those in ApoE−/−AnxA8+/+. BMT showed that hematopoietic AnxA8 deficiency had no effect on atherosclerotic progression. Oxidized low‐density lipoprotein (ox‐LDL) increased AnxA8 expression in murine aortic endothelial cells (MAECs). In vitro experiments revealed that AnxA8 deficiency in MAECs suppressed P/E‐selectin and CD31 expression and secretion induced by ox‐LDL with a concomitant reduction in platelet and leukocyte adhesion. Intravital microscopy confirmed the reduction in leukocyte and platelet adhesion in ApoE−/−AnxA8−/− mice. Finally, endothelial‐specific silencing of AnxA8 decreased atherosclerosis progression. Conclusion Our findings demonstrate that AnxA8 promotes the progression of atherosclerosis by modulating endothelial−leukocyte interactions. Interventions capable of reducing AnxA8 expression in endothelial cells may delay atherosclerotic plaque progression. Key points This study shows that AnxA8 is upregulated in aorta of atheroprone mice and in human atherosclerotic plaques. Germline AnxA8 deficiency reduces platelet and leukocyte recruitment to activated endothelium as well as atherosclerotic burden, plaque size, and macrophage accumulation in mice. AnxA8 regulates oxLDL‐induced adhesion molecules expression in aortic endothelial cells. Our data strongly suggest that AnxA8 promotes disease progression through regulation of adhesion and influx of immune cells to the intima. Endothelial specific silencing of AnxA8 reduced atherosclerosis progression. Therapeutic interventions to reduce AnxA8 expression may delay atherosclerosis progression.https://doi.org/10.1002/ctm2.70176AnxA8atherosclerosisinflammation
spellingShingle Carmen Gutiérrez‐Muñoz
Rafael Blázquez‐Serra
Irene San Sebastian‐Jaraba
Sandra Sanz‐Andrea
Maria J. Fernández‐Gómez
Gonzalo Nuñez‐Moreno
Pablo Mínguez
Joan Carles Escolá‐Gil
Paula Nogales
Veronique Ollivier
Jose L. Martín‐Ventura
Benoit Ho‐Tin Noe
Ursula Rescher
Nerea Méndez‐Barbero
Luis M. Blanco‐Colio
Annexin A8 deficiency delays atherosclerosis progression
Clinical and Translational Medicine
AnxA8
atherosclerosis
inflammation
title Annexin A8 deficiency delays atherosclerosis progression
title_full Annexin A8 deficiency delays atherosclerosis progression
title_fullStr Annexin A8 deficiency delays atherosclerosis progression
title_full_unstemmed Annexin A8 deficiency delays atherosclerosis progression
title_short Annexin A8 deficiency delays atherosclerosis progression
title_sort annexin a8 deficiency delays atherosclerosis progression
topic AnxA8
atherosclerosis
inflammation
url https://doi.org/10.1002/ctm2.70176
work_keys_str_mv AT carmengutierrezmunoz annexina8deficiencydelaysatherosclerosisprogression
AT rafaelblazquezserra annexina8deficiencydelaysatherosclerosisprogression
AT irenesansebastianjaraba annexina8deficiencydelaysatherosclerosisprogression
AT sandrasanzandrea annexina8deficiencydelaysatherosclerosisprogression
AT mariajfernandezgomez annexina8deficiencydelaysatherosclerosisprogression
AT gonzalonunezmoreno annexina8deficiencydelaysatherosclerosisprogression
AT pablominguez annexina8deficiencydelaysatherosclerosisprogression
AT joancarlesescolagil annexina8deficiencydelaysatherosclerosisprogression
AT paulanogales annexina8deficiencydelaysatherosclerosisprogression
AT veroniqueollivier annexina8deficiencydelaysatherosclerosisprogression
AT joselmartinventura annexina8deficiencydelaysatherosclerosisprogression
AT benoithotinnoe annexina8deficiencydelaysatherosclerosisprogression
AT ursularescher annexina8deficiencydelaysatherosclerosisprogression
AT nereamendezbarbero annexina8deficiencydelaysatherosclerosisprogression
AT luismblancocolio annexina8deficiencydelaysatherosclerosisprogression